TGACC home page
First time visitors
About The TGACC
FAQ
the Code
Approvals
Complaints
Launching a product
Events
Home
Overview
The Code

Guide to the Advertising of Non-prescription Medicines to Consumers

Amendments

Restricted Representations

Guidelines for the Levels and Kinds of Evidence to Support Claims for Therapeutic Goods

Industry Codes

Amendments to the Code

16/07/03
APPENDIX 5 - Appendix 5
Also see APPENDIX 5...
Add the following introductory paragraph and criteria to Appendix 5 -

In considering whether or not to make a recommendation to the Secretary to amend Appendix 5 so as to permit therapeutic goods to be advertised to persons under the age of 18, the TGACC will satisfy itself on the following factors (which are not exhaustive):

1. That the likely audience could be expected to have the knowledge and maturity to self-diagnose and self-manage the condition(s) for which the goods are to be advertised; 2. That the advertising of the goods to the likely audience could reasonably be expected to deliver to them significant health benefits or significant improvements to their quality of life; 3. That the risk of over-use, misuse or inappropriate use in the likely audience is insignificant; 4. That over-use, misuse or inappropriate use of the goods is unlikely to cause significant harm; 5. That the advertising of the goods can be confined to the intended audience.

< Back